A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis

NCT03393013 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis
Systemic Lupus Erythematosus

Interventions

DRUG: KZR-616

Sponsor

Kezar Life Sciences, Inc.